CoChat

Multiple sclerosis endophenotypes identified by high-dimensional blood signatures are associated with distinct disease trajectories

Gross, Catharina C., Schulte-Mecklenbeck, Andreas, Steinberg, Olga V., Wirth, Timo, Lauks, Sarah, Bittner, Stefan, Schindler, Patrick, Baranzini, Sergio E., Groppa, Sergiu, Bellmann-Strobl, Judith, Bünger, Nora, Chien, Claudia, Dawin, Eva, Eveslage, Maria, Fleischer, Vinzenz, Gonzalez-Escamilla, Gabriel, Gisevius, Barbara, Haas, Jürgen, Kerschensteiner, Martin, Kirstein, Lucienne, Korsukewitz, Catharina, Lohmann, Lisa, Lünemann, Jan D., Luessi, Felix, Meyer zu Hörste, Gerd, Motte, Jeremias, Ruck, Tobias, Ruprecht, Klemens, Schwab, Nicholas, Steffen, Falk, Meuth, Sven G., Paul, Friedemann, Wildemann, Brigitte, Kümpfel, Tania, Gold, Ralf, Hahn, Tim, Zipp, Frauke, Klotz, Luisa, Wiendl, Heinz, German Competence Network Multiple Sclerosis (KKNMS), Aktas, Orhan, Ayzenberg, Ilya, Bahn, Erik, Bayas, Antonios, Berger, Klaus, Berthele, Achim, Brück, Wolfgang, Engel, Sina, Friede, Tim, Heesen, Christoph, Hellwig, Kerstin, Hemmer, Bernhard, Kallmann, Boris, Kleiter, Ingo, Korn, Thomas, Kowarik, Markus, Linker, Ralf, Lukas, Carsten, Mäurer, Mathias, Mühlau, Mark, Nischwitz, Sandra, Salmen, Anke, Sauer, Edda, Stadelmann-Nessler, Christine, Then Bergh, Florian, Trebst, Corinna, Tumani, Hayrettin, Warnke, Clemens, Weber, Martin S. · 2024 · Science Translational Medicine
Cited by 52

The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.

Abstract

One of the biggest challenges in managing multiple sclerosis is the heterogeneity of clinical manifestations and progression trajectories. It still remains to be elucidated whether this heterogeneity is reflected by discrete immune signatures in the blood as a surrogate of disease pathophysiology. Accordingly, individualized treatment selection based on immunobiological principles is still not feasible. Using two independent multicentric longitudinal cohorts of patients with early multiple sclerosis ( n = 309 discovery and n = 232 validation), we were able to identify three distinct peripheral blood immunological endophenotypes by a combination of high-dimensional flow cytometry and serum proteomics, followed by unsupervised clustering. Longitudinal clinical and paraclinical follow-up data collected for the cohorts revealed that these endophenotypes were associated with disease trajectories of inflammation versus early structural damage. Investigating the capacity of immunotherapies to normalize endophenotype-specific immune signatures revealed discrete effect sizes as illustrated by the limited effect of interferon-β on endophenotype 3–related immune signatures. Accordingly, patients who fell into endophenotype 3 subsequently treated with interferon-β exhibited higher disease progression and MRI activity over a 4-year follow-up compared with treatment with other therapies. We therefore propose that ascertaining a patient’s blood immune signature before immunomodulatory treatment initiation may facilitate prediction of clinical disease trajectories and enable personalized treatment decisions based on pathobiological principles.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1126/scitranslmed.ade8560

Cites

15 of 15 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 15 references

Cited by

See all 52

Metadata

Authors
Gross, C. C., Schulte-Mecklenbeck, A., Steinberg, O. V., Wirth, T., Lauks, S., Bittner, S., Schindler, P., Baranzini, S. E., Groppa, S., Bellmann-Strobl, J., Bünger, N., Chien, C., Dawin, E., Eveslage, M., Fleischer, V., Gonzalez-Escamilla, G., Gisevius, B., Haas, J., Kerschensteiner, M., Kirstein, L., Korsukewitz, C., Lohmann, L., Lünemann, J. D., Luessi, F., Meyer zu Hörste, G., Motte, J., Ruck, T., Ruprecht, K., Schwab, N., Steffen, F., Meuth, S. G., Paul, F., Wildemann, B., Kümpfel, T., Gold, R., Hahn, T., Zipp, F., Klotz, L., Wiendl, H., German Competence Network Multiple Sclerosis (KKNMS), Aktas, O., Ayzenberg, I., Bahn, E., Bayas, A., Berger, K., Berthele, A., Brück, W., Engel, S., Friede, T., Heesen, C., Hellwig, K., Hemmer, B., Kallmann, B., Kleiter, I., Korn, T., Kowarik, M., Linker, R., Lukas, C., Mäurer, M., Mühlau, M., Nischwitz, S., Salmen, A., Sauer, E., Stadelmann-Nessler, C., Then Bergh, F., Trebst, C., Tumani, H., Warnke, C., & Weber, M. S.
Venue
Science Translational Medicine
Published
2024-03-27
Volume
16
Issue
740
Pages
eade8560-eade8560
ISSN
  • 1946-6234 (ISSN-L)
  • 1946-6242
OpenAlex
W4393235085
Cited by
52
References
15
FWCI
13.63
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Multiple sclerosis endophenotypes identified by high-dimensional blood signatures are associated with distinct disease trajectories. https://app.cochat.ai/papers/10.1126/scitranslmed.ade8560
The paper
Gross, C. C., Schulte-Mecklenbeck, A., Steinberg, O. V., Wirth, T., Lauks, S., Bittner, S., Schindler, P., Baranzini, S. E., Groppa, S., Bellmann-Strobl, J., Bünger, N., Chien, C., Dawin, E., Eveslage, M., Fleischer, V., Gonzalez-Escamilla, G., Gisevius, B., Haas, J., Kerschensteiner, M., . . . Weber, M. S. (2024). Multiple sclerosis endophenotypes identified by high-dimensional blood signatures are associated with distinct disease trajectories. Science Translational Medicine. https://doi.org/10.1126/scitranslmed.ade8560

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.